30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
I recently had the opportunity to visit with Michele Edwards, Partner at StoneTurn, to consider som...
Read More >
Investments in private companies by way of share purchases from existing shareholders (secondary tra...
Read More >
Buyers in M&A deals often contend that they value a target company based on the seller’s representa...
Read More >
On May 3, 2019, the SEC issued a proposed rule that would amend the financial statement requirements...
Read More >
The EEOC has been no stranger to headlines in recent months, particularly on the issue of equal pay....
Read More >
The Coronavirus Aid, Relief, and Economic Security (CARES) Act, among other economic stimulus measur...
Read More >